Table 3 Random effect probit models concerning general practitioners and gynaecologists separately (only significant coefficients shown)

(Intercept)

NS*

NS*

Population of women targeted

<  0.01

<  0.01

- Unscreened

(0.27; 0.76)

<  0.01

NS*

- Women over 50 years old

(−0.73; −0.22)

<  0.01

(− 0.92; − 0.10)

0.01

- From deprived areas

 (-0.58; -0.09)

<  0.01

 (-0.99; -0.24)

<  0.01

- From areas with low rates of screening

(0.05; 0.60)

0.02

(0.25; 1.15)

<  0.01

- Receiving free supplementary universal health care

NS*

NS*

Stakeholders in act of screening

<  0.01

<  0.01

- Current stakeholders and state-registered nurses

(0.24; 0.63)

<  0.01

NS*

- Current stakeholders and state-registered nurses and radiologists during mammography

(0.12; 0.48)

<  0.01

(− 0.65; − 0.10)

<  0.01

- Current stakeholders and radiologists during mammography

NS*

NS*

Technique(s) of uterine cervical cancer screening

<  0.01

<  0.01

- Self-collected oncogenic papillomavirus testing

(− 0.78; − 0.44)

<  0.01

(− 0.71; − 0.18)

0.01

- Choice between pap smear or self-collected oncogenic papillomavirus testing

(− 0.32; −4e⁻³)

<  0.05

NS*

Inducement to women to perform screening

<  0.01

NS*

- Mailed invitation involving attending physician

(0.22; 0.66)

<  0.01

- Mailed invitation without involving attending physician

(−0.66; − 0.19)

<  0.01

- Delivery of screening prescription by student health services

 (-0.59; -0.06)

0.02

- Mailing of screening prescription

NS*

- Delivery of screening prescription by occupational physicians

NS*

Inducement to general practitioners

<  0.01

0.01

- Communication of lists of unscreened women to their practitioner

(0.48; 0.94)

<  0.01

(0.02; 0.72)

0.04

- Fixed fee for time spent on screening

(0.17; 0.66)

<  0.01

NS*

- Increasing fee for Pap smear

NS*

NS*

- Increasing fee for performance concerning uterine cervical cancer screening

NS*

NS*

- Remuneration of consultations dedicated to uterine cervical cancer screening

NS*

NS*